n.ekstrom
Submits third-party assay reports on material purchased directly. Based in Tilburg.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.07%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041895 | BPC-157 | JEEP | JEEP-2509-G3860 | Janoshik | 2026-Q1 | 99.88 | 3.56 | 90.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020154 | Liraglutide | GGPeps | GGPE-2505-W9629 | VendorInvestigate | 2025-Q4 | 97.50 | 7.41 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018782 | TB-500 | QSC | QSC-2504-T7980 | Janoshik | 2025-Q2 | 99.93 | 4.00 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018443 | Semaglutide | WWB | WWB-2501-Y2776 | Janoshik | 2025-Q1 | 99.08 | 3.86 | 88.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020490 | Sermorelin | KP | KP-2501-V5157 | Medutest | 2025-Q1 | 98.62 | 4.90 | 107.0 | Laboratory-retained | 1 | FAIL |
| AX-2024-004878 | NAD+ | SWB | SWB-2405-L5945 | Janoshik | 2024-Q3 | 99.07 | 9.30 | 100.0 | Supplier-supplied | 0 | PASS |